Intelligence / Healthtech / New Clinical Trials / MED-EL Elektromedizinische Geräte GmbH
Clinicaltrial registered28 Oct 2026
MED-EL Elektromedizinische Geräte GmbH
28 Oct 2026: Trial registered · Mi2000 TICI Follow-up. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 28 Oct 2026
- Title
- Mi2000 TICI Follow-up
- Conditions
- Hearing Loss, Binaural, Cochlear Implantation
- Study Type
- Observational
- Status
- Recruiting
- Countries
- Austria, Belgium, Germany, Poland
- Country
- Austria
- Reference
- NCT07902414
- Location
- Austria, Belgium, Germany
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at MED-EL Elektromedizinische Geräte GmbH
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for MED-EL Elektromedizinische Geräte GmbH in our registers.
30 OctMED-EL Elektromedizinische Geräte GmbHtrial registered · HealthtechClinical27 OctMED-EL Elektromedizinische Geräte GmbHtrial registered · HealthtechClinical
More from Austria
New Clinical Trials
16 NovPolymedics Innovations Inc.trial registered · Influence of SUPRA SDRM on the Healing of Chronic WoundsClinical12 NovCroma-Pharma GmbHtrial registered · Revitalis - Midface (Cheek Area)Clinical12 NovYGION Biomedical GmbHtrial registered · First Study Evaluating the Safety and Dosage of YG-01 in Patients With GlioblastomaClinical9 NovAqua Therapeutics, Inc.trial registered · Clinical Study on the Safety and the Performance of an Endometrial Ablation System in Women With Abnormal Uterine Bleeding (AUB) and Previous Cesarean DeliveryClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical28 OctNuvascular Inctrial registered · The NUVASCULAR HARBOR Occlusion Device EU StudyClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.